NIRVANA APPOINTS NEW CHIEF FINANCIAL OFFICER

Connie Hang has resigned as chief financial officer of Nirvana Life Sciences Inc. The company thanks Ms. Hang for her work as chief financial officer over the last two years; she will continue serving the company as a contractor.

Annie Storey, CPA, CA, BBA, has been appointed as chief financial officer, effective immediately. Ms. Storey, a director of the company since 2017, brings over 25 years of experience in accounting, auditing, financial reporting and corporate services for Canadian and U.S. public companies in the mining, entertainment and biotechnology sectors.

Ms. Storey has a keen interest in the development of new approaches to manage addictions and currently serves as a director of the advocacy group Moms Stop the Harm.

About Nirvana Life Sciences Inc.

Nirvana Life Sciences is an innovator in the emerging psychedelic space. Its business model combines the development of novel formulations for drug development with the development of laboratory space to support continuing development and manufacturing. At Nirvana, the company believes that psilocybin-derived medicines can play a leading role in reducing the impacts of the opioid crisis and build healthier communities.

We seek Safe Harbor.